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Background and Objectives: Patients undergoing endoscopic gastrostomy (PEG) present with protein-energy 
malnutrition (PEM) but little is known about zinc status. Our aim was to evaluate serum zinc, its relationship with 
serum proteins and with the nature of the underlying disorder, during the first 3 months of PEG feeding. Methods 
and Study Design: Prospective observational study during a 3-month period after gastrostomy. Data was collect-
ed at initial PEG procedure (T0), after 4 (T1) and 12 weeks (T3). Initial evaluation included: age, gender, disorder 
causing dysphagia, Neurological Dysphagia (ND) or Head and Neck Cancer (HNC), NRS-2002, BMI, albumin, 
transferrin, zinc. At T1 and T3, a blood sample was collected for zinc, albumin, transferrin. Serum zinc evaluation 
was performed with ICP-AES – Inductively Coupled Plasma-Atomic Emission Spectroscopy. Patients were fed 
with homemade meals. Results: A total of 146 patients (89 males), 21-95 years were studied: HNC-56, ND-90 
and low BMI in 78. Initial low zinc in 122; low albumin in 77, low transferrin in 94; low values for both proteins 
in 66. Regarding the serum protein evolution, their levels increase T0-T3, most patients reaching normal values. 
zinc has a slower evolution, most patients still displaying low zinc at T3. Significant differences between the 3 
moments for zinc (p=0.011), albumin (p<0.0001) and transferrin (p=0.014). Conclusion: PEG patients are prone 
to PEM and zinc deficiency. Most patients present decreased zinc, suggesting that zinc deficiency is common in 
PEG candidates and is not corrected during 3 months of enteral feeding. Zinc deficiency should be expected and 
teams taking care of PEG patients should use zinc supplementation. 
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INTRODUCTION 
Zinc (Zn) is one of the most important trace elements and 
is involved in three major types of metabolic functions: 
catalytic, regulatory and structural.1-3 Zn may be involved 
in macular degeneration in the elderly, common flu, pre-
vention and treatment of diarrhea in children and treat-
ment of Wilson’s disease.4,5 Zn deficient patients may 
develop immune dysfunction, increased oxidative stress, 
increased generation of inflammatory cytokines and 
growth retardation. The most severe deficiency is dis-
played by patients with the rare Acrodermatites Entero-
pathica.6 The World Health Organization highlighted Zn 
deficiency as one the 10 major factors contributing to 
disease in developing countries, potentially affecting 
nearly one third of world population.4,7 The risk of devel-
oping Zn deficiency is higher in vulnerable groups such 
as elderly, children, alcoholics and patients with chronic 
diseases.1,2,8-10 It can also be associated with short bowel 
syndrome, excessive GI losses (diarrhea, emesis and high 
 
 
output fistulas) and long term parenteral nutrition.11 
Zn deficiency is frequently caused by deficient inges-
tion.12 This can result from dysphagia caused by a neuro-
logical disorder or from an obstructive disease. Regard-
less of the underlying disease, dysphagia reduces the oral 
intake by decreasing deglutition efficiency and safety, 
leading to nutrient depletion.13-15 If dysphagia causes in-
sufficient oral intake and there is no other disturbance of 
digestive tract, tube feeding is the obvious option.13 Per-
cutaneous endoscopic gastrostomy (PEG) is a simple and 
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safe method for providing enteral nutrition to patients 
with dysphagia in cases where tube feeding is required for 
longer than 3 weeks.16-18 Frequently, long-term dysphagic 
patients that underwent PEG have reduced oral intake 
weeks before the procedure and often present weight loss 
and protein energy malnutrition (PEM) when gastrostomy 
is performed. Serum proteins, such as albumin and trans-
ferrin, are classic markers for PEM and have been con-
sidered a major feature of malnutrition. Nevertheless, 
these proteins are also markers of inflammatory activity 
and should be used with other nutritional markers. 
Patients that underwent gastrostomy frequently present 
PEM but, as far as we know, there are no systematic stud-
ies on Zn or other trace elements in PEG patients except 
the ones from our team.19,20 The aims of present study 
were: (I) Evaluation of serum Zn concentration in dys-
phagic patients undergoing gastrostomy for enteral feed-
ing and comparison of the two main groups of underlying 
disorders: head or neck cancer (HNC) and neurological 
dysphagia (ND); (II) Comparison of serum Zn concentra-
tion in three moments: at the time of the PEG procedure 
(T0), and after 4 (T1) and 12 (T3) weeks of PEG feeding, 
and (III) Assessing the relationship between serum Zn 
and serum albumin and transferrin concentrations and its 
evolution in dysphagic patients that underwent gastros-
tomy for enteral feeding. 
 
MATERIALS AND METHODS 
Subjects 
All the adult (≥18 years) patients with long term dyspha-
gia, submitted to endoscopic gastrostomy in order to im-
prove nutritional care were invited to participate in this 
study. Exclusion criteria were refusal to participate in the 
present study and gastrostomy performed in other clinical 
settings different from HNC or ND. According to the 
underlying cause of dysphagia, two study groups were 
evaluated: (I) HNC, including esophageal proximal can-
cer and (II) ND, including acute and chronic neurologic 
disorders.  
After the PEG procedure, all patients were discharged 
from our hospital and lived either in nursing homes or in 
their own homes, being followed by the Enteral Feeding 
Team (the dietitian, the gastroenterologist and the nurse) 
at the Artificial Nutrition Outpatient Consultation. Pa-
tients were mostly fed with home-made meals since the 
Portuguese Health System does not reimburse enteral 
feeding products, rendering them too expensive for pa-
tients and their families. Only when these meals could not 
account for the patients’ nutritional needs (less than 10% 
of the cases) are the patients were provided with enteral 
feeding products, albeit for short periods and never ex-
ceeding one third of the total energy intake. 
 
Initial evaluation 
Nutritional assessment 
Body mass index (BMI) was obtained in most patients 
using the equation Weight/Height2. Weight was measured 
using a calibrated digital scale. Height was measured us-
ing a stadiometer. If patients were bedridden and could 
not stand up for weight and height evaluation, BMI was 
estimated using the Mid Upper Arm Circumference and 
regression equations described by Powell-Tuck/Hennessy, 
which have previously been proved to provide a reliable 
BMI estimation in PEGpatients.21 BMI cut-off point for 
malnutrition was defined for values below 18.5 kg/m2 for 
adult patients younger than 65 years old and below 22 
kg/m2 for patients with 65 years or older. 
Energy intake was calculated using a 3-day dietary dia-
ry. Nutritional Risk Screening (NRS-2002) was used to 
assess nutritional risk but, as many of these patients have 
major speech difficulties due to neurological disorders or 
head and neck cancer, tools that depend on oral commu-
nication were generally unreliable. 
 
Biochemical evaluation 
We evaluated Zn concentration at the time of PEG proce-
dure (T0) and also during the follow-up after four (T1, 
nearly one month) and twelve weeks (T3, nearly three 
months). Simultaneously, we evaluated albumin and 
transferrin concentration, serum markers of malnutrition 
and/or inflammation. 
A blood sample was obtained from these patients be-
fore the procedure to add to the nutritional evaluation. 
Blood samples were obtained between 8:00 and 10:00 
AM following at least 12 hours of fasting. Part of each 
blood sample was used for the standard PEG-patient 
evaluation, which includes serum proteins assessment. 
The remainder of the sample was collected into metal-
free tubes for Zn assessment. The samples were centri-
fuged and serum was stored at -80ºC. Serum Zn was 
evaluated using ICP-AES – Inductively Coupled Plasma-
Atomic Emission Spectroscopy. 
We considered normal values: 70-120 µg/dL for Zn, 
≥35 g/L for albumin, and ≥2 g/L for transferrin. 
 
Follow-up 
Patients were evaluated by Enteral Feeding Team at 4 and 
12 weeks after PEG procedure, being the laboratory as-
sessment similar to the initial. BMI at 4 and 12 weeks 
was not included in the present study. No nutritional risk 
was evaluated at T1 or T3. 
 
Statistical analysis 
Statistical analysis was performed using SPSS version 
22.0. Results were considered significant at a 5% level. 
To test the normality of the data, we used the Kolmogo-
rov-Smirnov test fitting, performing the analysis for the 
whole sample and for each group individually (ND and 
HNC). To compare the three moments (the moment of the 
PEG procedure, and both four and twelve weeks post-
procedure) we employed ANOVA test for repeated 
measures, since the assumption of normality was verified 
(p>0.05 for every test) and the Sphericity was verified 
using the Mauchly’s Test of Sphericity. To compare the 
two study groups (ND and HNC) we used the t-test for 
two independent samples. To study the relationship be-
tween albumin, transferrin and Zn we used the Pearson 
correlation coefficient. 
 
Ethical considerations 
This study was approved by the Hospital Ethics Commit-
tee (n 016/2011). All subjects were informed of the pur-
pose and procedures of the study and gave their informed 
consent. 
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RESULTS 
Evaluation in the day of gastrostomy (T0)–Table 1 
This study included 146 dysphagic patients who were 
admitted for PEG: 89 men and 57 women, with ages 
ranging between 21-95 years (91 patients ≥65 years old) 
and a mean age of 68.2 years (SD=14.2). Patients were 
divided in two groups according to the underlying disease: 
head and neck cancer (HNC: 56 patients) and neurologi-
cal dysphagia (ND: 90 patients). HNC were located in the 
oral cavity (n=10), larynx (n=15), pharynx (n=20), and 
proximal esophagus (n=11). ND group included strokes 
(n=29), dementias (n=20), neurosurgical injuries (n=24), 
amyotrophic lateral sclerosis (n=6) and other neurological 
diseases (n=11). 
Before gastrostomy, all patients had dysphagia for at 
least one month after the diagnosis of the underlying dis-
ease. All of them presented low oral ingestion, less than 
50% of their caloric needs. They were clinically stable at 
the moment of gastrostomy, with unstable patients being 
excluded or postponed. Nutritional Risk Screening (NRS-
2002) presented a score ≥3 in all patients, signaling the 
nutritional risk.  
 
BMI  
According to age, patients were split into two groups for 
nutritional status classification according to BMI: below 
65 years old and 65 and older. In the former group (n=55), 
BMI ranged between 13 and 38.5 kg/m2, with a mean 
value of 21 kg/m2. For the latter group (n=91), BMI 
ranged between 13.8 kg/m2 and 34.1 kg/m2, with a mean 
value of 21.25 kg/m2. From low BMI patients, 47 (52%) 
were from the ND group and 31 (55.3%) were from the 
HNC group. Low BMI was found in 56 patients (61.5%) 
from the older group and in 22 patients (40%) from the 
younger group. 
 
Zn  
Zn concentration was evaluated in 146 patients, ranging 
31-114 µg/dL (normal range: 70-120 µg/dL). The mean 
value was 53.9±16.2 µg/dL, with a median of 51 µg/dL. 
Zn was low in 122 patients (84%), while 24 patients (16%) 
had normal values, although close to the lower limit. 
From these 24 patients, 17 were from the neurosurgery 
ward, presenting sudden conditions and acute brain le-
sions from trauma or surgery; from the remaining 7, 4 had 
HNC and 3 suffered from progressive neurological disor-
ders. From the 122 patients with low Zn, 52 presented 
HNC, (93% of the HNC group) and 70 were from the ND 
group (78% of the ND group). 
 
Albumin  
From 144 patients, we found a mean albumin of 
34±0.4g/L, with values ranging from 14 to 52 g/L. More 
than half of the patients (n=77, 53%) presented low al-
bumin, from which 24 belonged to the HNC group and 53 
to ND group. 
 
Transferrin  
From 144 patients, we found a mean transferrin of 1.84 
g/L, with values ranging from 0.74 to 3.31 g/L. Nearly 
two-thirds of the patients (n=94, 65%) presented with low 
transferrin. Looking at two main groups (HNC and ND), 
the mean transferrin values were 1.86 g/L and 1.87 g/L, 
respectively. There were no major differences between 
the two main groups of underlying diseases (63% of HNC 
and 50% of ND) neither between elderly or patients under 
65 years old. Nearly half of the patients (n=66, 46%) pre-
sented low serum levels of both proteins. 
 
Follow-up 4 weeks (T1) – Table 2 
After 4 weeks of PEG procedure (T1), 89 patients were 
followed up (56 men, 33women). Twenty-five patients 
died and 29 were lost to follow-up. Three patients were 
not compliant with PEG feeding and their tubes were re-
moved  
 
Zn  
From the initial 122 patients with low Zn, 72 maintained 
their low values and 3 improved their values, 22 were lost 
to follow-up, 23 died and 2 had the tubes removed. From 
the initial 24 patients with normal Zn, 6 patients main-
tained their values, 8 decreased their values, 7 were lost 
to follow-up, 2 died and 1 had the tube removed. From 
the remaining 89 patients, 9 had Zn in the normal range 
while 80 patients had low values. 
 
Albumin  
From the initial 144 patients with albumin assessed 88 
were followed-up. From the initial 67 patients with nor-
mal albumin, 39 maintained their values, 4 decreased 
their values, 16 were lost to follow-up, 5 died and 3 had 
the tubes removed. From the initial 77 patients with low 
albumin, 25 patients maintained their low values, 20 im-
proved their values, 12 were lost to follow-up and 20 died.  
 
Transferrin 
From the initial 144 patients with albumin assessed 88 
were followed-up. From the initial 50 patients with nor-
mal transferrin, 24 maintained their values, 8 decreased 
their values, 10 were lost to follow-up, 5 died and 3 had 
Table 1. Characteristics of the study population 
(n=146) 
 
Characteristics n or mean (SD) 
Age (years)  
Max 95 
Min 21 
Mean (SD) 68.2 (14.2) 
≥65 years 90 
<65 years 56 
Gender  
Women 57 
Men 89 
Group diagnosis  
Head neck cancer (HNC) 56 
Oral cavity 1 
Pharynx 20 
Larynx 15 
Proximal Esophagus 11 
Neurological dysphagia (ND) 90 
Stroke 29 
Dementia 20 
Neurosurgical Injury 24 
Amyotrophic lateral sclerosis 6 
Other disorders 11 
 
 
230                                      CA Santos, J Fonseca, MTM Lopes, E Carolino and AS Guerreiro 
the tubes removed. From the initial 94 patients with low 
transferrin, 38 patients maintained their low values 18 
improved their values, 18 were lost to follow-up and 20 
died.  
From the 9 patients who showed normal Zn levels, 3 
had normal albumin and 2 had normal transferrin levels. 
 
Follow-up 12 weeks (T3) – Table 2 
After 12 weeks of PEG procedure (T3), 40 patients were 
followed up. Ten patients died between the 4th and the 
12th week after gastrostomy. Thirty-seven were lost to 
follow-up and two patients had the PEG tube removed.  
 
Zn  
From these 40 patients, 8 (20%) had serum Zn concentra-
tion into normal range and 32 (80%) under normal range. 
From the previous evaluation (T1), 2 maintained normal 
values, 32 maintained low values and 6 improved their 
values. 
 
Albumin  
From these 40 patients, 30 (75%) patients had normal 
values, while 10 (25%) had values under normal range. 
From the previous evaluation (T1), 27 patients main-
tained normal values, 8 maintained low values, 3 in-
creased their values from low to the normal range and 2 
decreases to low range.  
 
Transferrin  
From these 40 patients, 27 (68%) had normal values 
while 13 (33%) were under normal range. From the pre-
vious evaluation (T1), 20 maintained values into normal 
range, 7 improved their values into the normal range, 12 
maintained their values low and 1 decreased for low val-
ues.  
 
Evolution of Zn concentration after four weeks and 
twelve weeks, and its relationship with proteins and un-
derlying diseases (Table 2) 
For Zn concentration, statistically significant differences 
were found between at least one of the three moments (by 
Huynh-Feldt statistics, since there was no sphericity, 
F1.681=5.181, p=0.011), verifying the paired multiple 
comparisons stating that T0 and T1 (p=0.041), T0 and T3 
(p=0.011), and rejecting the hypothesis that T1 and T3 
(p=0.122). Analyzing the graph of Figure 1, it was found 
Table 2. Evolution of zinc, Albumin and Transferrin concentrations 
 
 T0 T1 T3 p value 
Zinc (µg/dL), n 
MeanSD  
146 
53.94±16.20 
89 
54.91.71 
40 
55.21.94 
 
0.011* 
<70, n (%) 122 (84) 80 (89) 32 (80)  
≥70, n (%) 24 (16) 9 (11) 8 (20)  
Albumin (g/L), n  
MeanSD  
144 
34 g/l±3.5 
88 
3.660.07 
40 
3.820.09 
 
<0.0001* 
<35L, n (%) 77 (53) 29 (33) 10 (25)  
≥35, n (%) 67 (47) 59 (67) 30 (75)  
Transferrin (g/L), n  
MeanSD  
144 
1.840.6 
88 
1.970.65 
40 
2.080.81 
 
0.014* 
<2, n (%) 94 (65) 46 (52) 13 (32)  
≥2, n (%) 50 (35) 42 (48) 27 (68)  
 
*Statistically signify cant differences were found between the 3 moments. 
 
 
 
 
 
Figure 1. Evaluation of the Zn, albumin and transferrin concen-
tration in dysphagic patients at each moment (g/L) 
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that there is a statistically significant tendency to increase 
Zn concentration over time. Nevertheless, most patients 
present low serum Zn at T1 and T3, despite the slow se-
rum Zn increase over time. 
Looking at albumin concentration, statistically signifi-
cant differences were found comparing the 3 moments 
(by Huynh-Feldt statistics, since there was no sphericity, 
F1.859=13.988, p<0.0001), verifying the paired multiple 
comparisons that T0 andT1 (p=0.002), T0 and T3 
(p<0.0001) and T1 and T3 (p=0.017) (Figure 1). 
Concerning transferrin, statistically significant differ-
ences were also detected between at least one of the three 
moments (by F statistics, since there was sphericity, 
F2=4.478, p=0.014). By the paired multiple comparisons 
test, we conclude that T0 and T1 (p=0.048), T0 and T3 
(p=0.004), and reject the hypothesis that T1 and T3 
(p=0.281). Like the case of Zn, the concentration of trans-
ferrin has a tendency for increasing, even though the in-
crease from the second to the third moment was not sta-
tistically significant (Figure 1). 
Comparing Zn, albumin and transferrin concentrations 
in both groups (ND and HNC), statistically significant 
differences were found in: (1) Zn concentration at T0 
(t138.295=2.321, p=0.022); (2) albumin concentration at T0 
(t97.174=-3.156, p=0.002), at T1 (t94=-2.077, p=0.041) and 
at T3 (t56=-2.485, p=0.016) of evaluation (Figure 2). 
Table 3 contains the correlations between Zn, albumin 
and transferrin concentration at all evaluation moments. 
The Zn concentration in T3 was positively, albeit weakly, 
correlated with the concentration of albumin at T1 
(r=0.399, p=0.02) and T3 (r=0.471, p=0.002), and with 
transferrin concentration at T1 (r=0.343, p=0.021) and T3 
(r=0.368, p=0.020). The concentration of albumin and 
transferrin were significantly positively correlated 
(p<0.05 or p<0.01) and with intensities ranging between 
weak (r=0.315) and moderate to strong (r=0.797) at all 
evaluation moments. 
 
DISCUSSION 
Patients suffering from long standing dysphagia present a 
very high risk of developing malnutrition due to the re-
duced oral intake and the wasting effects of the underly-
ing diseases.22,23 This malnutrition may include both pro-
tein deficiency and trace element deficiency. Serum Zn 
concentration is the easiest and most commonly used 
marker of Zn status and correlates reasonably well with 
oral intake.1,24 In two previous studies, we identified low 
serum Zn concentrations in most patients that who had 
undergone endoscopic gastrostomy.19,20 These patients 
also exhibited deficiency in intracellular Zn, a harder to 
assess and less used measurement.19 
In our study we identified a large percentage of patients 
with Zn deficiency, probably as a result of dysphagia-
related insufficient oral intake prior to gastrostomy, simi-
lar to the results found in the literature in some cases of 
tube feeding and other clinical settings.25-28 Our findings 
are similar with other reports that suggested Zn deficien-
cy in humans was a frequent dietary problem accompany-
ing many chronic diseases, since lack of Zn storage has 
an important role in health status.29,30 Additionally, the 
literature mentions some risk conditions for Zn deficiency, 
like smoking and excessive alcohol intake, and these con-
ditions are typically fulfilled by most patients of the HNC 
group.8,31 Comparing Zn concentration between the two 
groups of long term dysphagic patients (HNC and ND), 
we identified similar Zn deficiency in both groups. Only 
4 patients with HNC had normal Zn, compared with 20 
patients from the ND group. Seventeen out of the 20 ND 
patients suffered traumatic brain injury, with an adequate 
 
             
 
 
Figure 2. Mean of Zn, albumin and transferrin concentration in 
ND and HNC groups at each moment.  
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oral intake prior to the accident. These 17 patients did not 
suffer along period of low intake as the others, since the 
trauma until the gastrostomy, and Zn deficiency had less 
time to develop. This suggests that, despite the excessive 
alcohol intake and smoking being very frequent in HNC 
patients, the development of Zn deficiency before the 
PEG procedure was mostly related with progressive low 
intake caused by dysphagia and less related with the na-
ture of the underlying disorder. 
Another aim of our study was to evaluate the relation-
ship between Zn concentration and serum markers of 
malnutrition and/or inflammation (albumin and transfer-
rin). Theoretically, Zn concentration levels may be posi-
tively related to the protein concentration, as a direct con-
sequence of starvation. Most of our patients displayed 
low serum proteins reflecting the reduced dietary intake 
and the activity of the underlying diseases. Roughly, half 
of the patients presented low BMI (n=78), which suggests 
a low prior intake and PEM. We identified a large number 
of patients with low Zn and low albumin and transferrin. 
More than half (53%) of the patients presented low albu-
min and nearly two-thirds (65%) presented with low 
transferrin. Almost half of the patients (46%) presented 
with low serum levels of both proteins. These low serum 
levels reflect previous low intake as well as the inflamma-
tory activity of the underlying disorders. 
Looking at T1 and T3 (4 weeks and 12 weeks after 
PEG procedure, respectively), we found similar results. 
Zn deficiency was constant in the majority of patients, but 
serum proteins were slowly increased over time suggest-
ing that enteral feeding by gastrostomy with homemade 
meals was not sufficient to compensate lower levels of Zn, 
but the macronutrients intake could be sufficient to in-
crease serum proteins. We did not find an important rela-
tionship in the evolution of Zn and albumin and transfer-
rin. 
Our study suggests that Zn deficiency in PEG patients, 
before and after the gastrostomy, is mostly related with 
long term low Zn intake and unrelated with the nature of 
the underlying disease. Zn deficiencies may be subclini-
cal and unapparent. Zn assessment should be included in 
the evaluation of dysphagic patients and, probably, in the 
evaluation of all malnourished patients regardless of the 
cause. As an alternative, Zn supplementation could be 
systematically considered in long term dysphagic patients. 
 
Limitations of the study 
The follow up of these PEG patients is very difficult, cre-
ating a limitation to our study. We had a large percentage 
of dropouts and a small percentage of PEG feeding in-
compliance and tube removal. Our team uses routinely 
the predictive model that foretells high mortality risk in 
PEG patients during the first 3 weeks after the procedure, 
as previously described and high risk patients are selected 
to nasogastric tube feeding.32 Nevertheless, some patients 
may die in the first few weeks. Also, some patients were 
either sent away to distant institutions, or lack sufficient 
social support. These limitations may explain the small 
number of published studies focusing on long term fol-
low-up of PEG patients. 
 
Conclusion 
Dysphagic PEG patients that underwent endoscopic gas-
trostomy were prone to present protein and energy malnu-
trition and Zn depletion. In our experience, serum Zn 
concentrations were severely decreased in the majority of 
patients, suggesting that low Zn is common in PEG can-
didates that undergo endoscopic gastrostomy. Our results 
also suggested that enteral nutrition, using home prepared 
meals, was not satisfactory to correct Zn deficiency but 
seemed to be sufficient to increase serum proteins. In the 
future, if serum Zn evaluation is not available for PEG 
candidates or PEG patients, Zn deficiency should be as-
sumed as very likely and supplementation should be pro-
vided. 
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